SA
Shubhangi Agarwal
About Shubhangi Agarwal
Data last updated:
Shubhangi Agarwal is a Director at Synokem Pharmaceuticals Limited (since 2022), Director at R. P. Multimetals Limited (since 2025) and Director at Shigan Quantum Technologies Limited (since 2021), and holds 5 more current directorships. The companies operate in Pharma, Metals and Minerals and Machinery and Equipment. The 7 current companies with reported revenue have a combined latest revenue of ₹1,978 Cr; the largest is Synokem Pharmaceuticals Limited at ₹791 Cr (FY 2025). Earlier, Shubhangi Agarwal was a Director at Nitin Lifesciences Limited (2023–2025) and Director at Abram Food Limited (2024) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2022 | 1983 | ₹791 Cr (FY 2025) | Active | |
| Director | 27 Mar 2025 | 1997 | ₹746 Cr (FY 2025) | Active | |
| Director | 10 Sep 2021 | 2008 | ₹212 Cr (FY 2025) | Active | |
| Director | 27 Nov 2025 | 2020 | ₹99.46 Cr (FY 2025) | Active | |
| Director | 30 Jul 2022 | 1962 | ₹64.83 Cr (FY 2024) | Active | |
| Director | 02 May 2023 | 2018 | ₹46.02 Cr (FY 2025) | Active | |
| Director | 28 Oct 2021 | 1991 | ₹18.15 Cr (FY 2025) | Active | |
| Designated Partner | 10 Apr 2025 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Sep 2023 | 2005 | ₹157 Cr (FY 2025) | Active | |
| Director | 10 Jan 2024 | 2009 | ₹64.09 Cr (FY 2025) | Active | |
| Director | 15 Dec 2023 | 2010 | ₹6.73 Cr (FY 2025) | Active | |
| Additional Director | 30 Jan 2023 | 2010 | ₹528 Cr (FY 2024) | Active | |
| Company Secretary | 02 Jun 2015 | 2004 | ₹28.70 Cr (FY 2025) | Active | |
| Additional Director | 17 May 2018 | 2010 | ₹2.56 Cr (FY 2025) | Active | |
| Designated Partner | 03 Apr 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shubhangi Agarwal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shubhangi Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shubhangi Agarwal
Shubhangi Agarwal currently holds 8 directorships: Synokem Pharmaceuticals Limited (Director, since 01 Apr 2022, revenue ₹791 Cr (FY 2025)); R. P. Multimetals Limited (Director, since 27 Mar 2025, revenue ₹746 Cr (FY 2025)); Shigan Quantum Technologies Limited (Director, since 10 Sep 2021, revenue ₹212 Cr (FY 2025)); Synokem Lifesciences Private Limited (Director, since 27 Nov 2025, revenue ₹99.46 Cr (FY 2025)); Algoquant Fintech Limited (Director, since 30 Jul 2022, revenue ₹64.83 Cr (FY 2024)); and 3 more.
Shubhangi Agarwal was first appointed on 02 Jun 2015 as Company Secretary at Kumon India Education Private Limited. The most recent appointment on record is 27 Nov 2025 at Synokem Lifesciences Private Limited.
The 7 current companies of Shubhangi Agarwal that report revenue have a combined latest revenue of ₹1,978 Cr: Synokem Pharmaceuticals Limited ₹791 Cr (FY 2025); R. P. Multimetals Limited ₹746 Cr (FY 2025); Shigan Quantum Technologies Limited ₹212 Cr (FY 2025); Synokem Lifesciences Private Limited ₹99.46 Cr (FY 2025); Algoquant Fintech Limited ₹64.83 Cr (FY 2024); and 2 more.
Shubhangi Agarwal held 7 earlier board appointments: Nitin Lifesciences Limited (Director, 27 Sep 2023 to 31 May 2025); Abram Food Limited (Director, 10 Jan 2024 to 31 May 2024); Prudence Technology Limited (Director, 15 Dec 2023 to 24 Apr 2024); As Krishna Associates Limited (Additional Director, 30 Jan 2023 to 31 May 2023); Kumon India Education Private Limited (Company Secretary, 02 Jun 2015 to 01 Feb 2017); and 2 more.
The current boards of Shubhangi Agarwal's companies include Abhinav Arora (Synokem Pharmaceuticals Limited), Dhiraj Poddar (Synokem Pharmaceuticals Limited), Gajanan Mohan Shenoy (Synokem Pharmaceuticals Limited), Sanjay Khurana (Synokem Pharmaceuticals Limited), Thomas Baby (Synokem Pharmaceuticals Limited), Vinay Kumar Purwar (Synokem Pharmaceuticals Limited), among others.